Indeed, the serum CORD assay of methylated RUNX3 resulted in a sensitivity of 50% for the detection of early gastric cancer, showing better performance compared to that in the previous reports (0–19.0%), as mentioned above [9,24]. This evidence concerns the gene RUNX3 and gastric cancer.